|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, May 27, 2016 ) Publisher's, 'Nektar Therapeutics - Product Pipeline Review - 2016', provides an overview of the Nektar Therapeutics's pharmaceutical research and development focus.
The report provides comprehensive information on the therapeutics under development by Nektar Therapeutics, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Other Key Points in Report:
- The report provides a snapshot of the pipeline therapeutic landscape of Nektar Therapeutics
- The report provides overview of Nektar Therapeutics including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Nektar Therapeutics's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Nektar Therapeutics's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001242084/sample
Table of Content: An Overview
Table of Contents 2
List of Tables 5
List of Figures 5
Nektar Therapeutics Snapshot 6
Nektar Therapeutics Overview 6
Key Information 6
Key Facts 6
Nektar Therapeutics - Research and Development Overview 7
Key Therapeutic Areas 7
Nektar Therapeutics - Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products - Monotherapy 11
Pipeline Products - Partnered Products 12
Partnered Products/Combination Treatment Modalities 13
Pipeline Products - Out-Licensed Products 14
Out-Licensed Products/Combination Treatment Modalities 15
Nektar Therapeutics - Pipeline Products Glance 16
Nektar Therapeutics - Late Stage Pipeline Products 16
Phase III Products/Combination Treatment Modalities 16
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001242084/discount
Nektar Therapeutics - Clinical Stage Pipeline Products 17
Phase II Products/Combination Treatment Modalities 17
Phase I Products/Combination Treatment Modalities 18
Nektar Therapeutics - Early Stage Pipeline Products 19
Preclinical Products/Combination Treatment Modalities 19
Discovery Products/Combination Treatment Modalities 20
Nektar Therapeutics - Drug Profiles 21
etirinotecan pegol 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
NKTR-181 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
NKTR-214 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
NKTR-171 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001242084/buy/1500
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us:
Email: sales@reportsweb.com
Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
